Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

NCT04088123 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inability to commence enrollment at institution, terminated on 9/23/20

Conditions

Thrombosis; Artery

Interventions

DRUG: Ticagrelor Oral Tablet [Brilinta]

Sponsor

George Washington University

Collaborators

[object Object]
[object Object]
[object Object]